Efficacy of Mizoribine (MZR) treatment for gastrointestinal symptoms in kidney transplant recipients using mycophenolate mofetil (MMF). - Open-label, multicenter, randomized, controlled trial –
Not Applicable
- Conditions
- Kidney transplantation
- Registration Number
- JPRN-UMIN000008649
- Lead Sponsor
- Tokyo Women Medical University, Dep. Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.currently undergoing acute rejection 2.positive for DSA 3.serum creatinine level of less than 3mg/dL 4.a severe infection other than viral infection 5.white blood cell counts of less than 3,000/mm3 6.pregnant women and women suspected of being pregnant 7.aged 19 or younger 8.considered inappropriate by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of GSRS results between the 1st day and a month later.
- Secondary Outcome Measures
Name Time Method